An Italian startup has developed software that could potentially revolutionize cancer care.
The software, called TECRIS, could also help physicians understand the genetic makeup of patients with cancer, which is often overlooked in cancer treatment.
TECRPISE is part of the TECER project, which was established by Italian startup TECer to develop tools to help physicians treat and prevent cancer.
TACS, the TICS-funded TECERCOS project, is helping to create TECRCIS.
« The goal is to help doctors make decisions in the first stage of cancer treatment, which can include managing the symptoms and quality of life, » said TECero CEO, Francesco Pecoraro.
« It could also be used to help cancer patients, such as cancer patients with a family history of cancer, get better access to cancer treatments, or to help researchers to better understand cancer.
The goal is that it can help the doctors and patients in the process. »
TECEROOMTECHNOLOGY, a software development company in Tuscany, Italy, has been working with TECERNOS, a research organization in Milan, Italy.
TOCRIS is based on TECERA software developed by TECERT, a small Italian company, with contributions from a number of universities.
TICER, the Italian startup, is a nonprofit organization.
TBCE, the nonprofit, is working with a consortium of universities, including the University of Milan, the University at Buffalo, and the University College London, to bring TECRSIR to the marketplace.
TETRIS was developed as part of a research project on the genomic, cellular, and molecular biology of cancers.
TEMPSIR, a collaboration between the University Hospital of Naples, University of Bordeaux, and University of Siena, was developed with support from the European Research Council.
TERCER is part-funded by the Italian government and TECTRIS is supported by the European Commission.
TECTRIS can be downloaded for free on TEMPCORE.TECER has partnered with a number and companies in the medical, medical imaging, and diagnostic industries, including: The Biomarkers Group (BGP), Biomodern Technologies, Biocare Inc., BioMedTech Solutions, BioSciences, Bio-Rad Laboratories, BioRx, BioTech Inc., Biologics, BioWave Inc., Genome Technologies, and MicroVision.
Bio-Signal Inc. is a spin-off from Biologix, a medical imaging company.
Biometrics Solutions has a proprietary technology for measuring blood samples, and has been developing a suite of tools for monitoring blood glucose, and detecting the effects of diabetes.
TEGRIS Software is a cloud platform for software developers and medical imaging companies that has been developed in collaboration with TEMPRINT, a company that specializes in imaging data collection and analysis.
TELAR is a platform for medical research that integrates data from multiple sources, including patient care, laboratory, and pathology data, in a single data store.
TEXRIS software is developed by the National Center for Biotechnology Information (NCBI), a nonprofit research organization.
This program supports the research of the NCBI’s Biological Research and Development Program.
TEOIS, a cloud software development platform for health care companies, is being developed by a consortium consisting of BioMedics, Theranos Inc., Therapeutics Inc., and the U.S. Department of Health and Human Services.
BioMedicin has developed the software to help healthcare organizations improve the quality of care and reduce cost and waste in health care.
TEREKESC is a medical research and development platform that helps hospitals and health care facilities manage clinical, surgical, and clinical laboratory data.
TLEFISC is being created by the University Health System in collaboration in part with Biologicysolutions, which has developed a suite for monitoring glucose, blood glucose levels, and other health metrics.
TREX, a new cloud platform developed by BioMedix, is designed to accelerate the delivery of healthcare solutions that can improve patients’ quality of experience and quality and cost effectiveness, while reducing healthcare costs.
TREE, a clinical testing platform developed in partnership with the University Hospitals of Cincinnati, was created to help universities, hospitals, and laboratories provide genomic testing services.
TESC, a commercial software development team based in Barcelona, Spain, is collaborating with Biogem, which specializes in diagnostic testing.
TIBERIS, which develops medical imaging and diagnostic products, is part funded by the UB Pharma Foundation.
TIO, a technology research and education platform, is focused on improving health data analysis.
IT Management is a public-private partnership focused on providing high-quality services to health care organizations.
TENUS is a global technology, health, and enterprise services company. TIGER